Enread

GenAI Research Platform for Life Sciences Leaders

Business Software
Non Active, Mar 2025 ceased to operate

Company Overview

Snapshot

Founded in March 2023 by Yagel Matuky and Tom Guterman, Enread operates with 1–10 employees. The company secured its first funding round from the Israel Innovation Authority in January 2024.

Business overview

Enread specializes in developing a generative AI platform designed to enhance productivity for professionals in the life sciences sector. The company's core technology streamlines research processes by automating tasks such as summarizing scientific literature into visual formats, creating interactive comparison tables, extracting experimental protocols, and generating presentations. Enread's platform integrates with existing software systems to accelerate workflows and facilitate data-driven decisions within the healthcare and life sciences industries.

Company Intelligence Q&A

What is Enread's primary focus?
Enread develops a generative AI platform aimed at enhancing productivity for professionals in the life sciences sector, streamlining research processes through automation.
When was Enread founded?
Enread was founded in March 2023.
Who are the founders of Enread?
Enread was co-founded by Yagel Matuky and Tom Guterman.
What is the status of Enread?
Enread is currently non-active and ceased to operate in March 2025.
Did Enread receive any funding?
Enread secured a Seed funding round in January 2024 from the Israel Innovation Authority.